The Doctors Company closes ProAssurance acquisition for $25 per share
Jun 26, 2026, 9:20 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The PRA equity will be delisted and converted to cash at $25; limited to no remaining liquidity or upside; historically, delistings following cash-out reduce price discovery and cap returns for remaining holders.
AI summary
What happened, with direct paths to the underlying reporting
The Doctors Company has completed its purchase of ProAssurance for $25 per share, valuing the deal at roughly $1.3 billion. ProAssurance will deregister and delist from NYSE, with public trading ceasing. The combined insurer will serve more than 200,000 healthcare professionals and manage about $12 billion in assets.
The Doctors Company completes ProAssurance acquisition for $25 per share.
Total deal value about $1.3 billion; PRA to delist NYSE.
Combined group to have $12 billion assets and 200k+ healthcare professionals.
PRA shareholders approved in June 2025; public trading ceased.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
U.S. stocks, including PRA, fell as Dow lost over 2,200 points. Analyst downgrade on PRA from Market Outperform to Market Perform. ProAssurance is set to be acquired at $25.00 per…
Analyst reiterates Market Outperform with a $20 price target. Q4 net investment income increased 9%; premiums fell slightly. Specialty P&C and Workers’ Comp segments met expected…
- ProAssurance (PRA) reported Q1 adjusted operating income of 8 cents per share, surpassing estimates - Operating revenues of $282 million, up 4.1% YoY, with improved underwriting…